BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15990159)

  • 1. Development of a time-resolved immunofluorometric assay for quantifying platelet-derived microparticles in human plasma.
    Michelsen AE; Wergeland R; Stokke O; Brosstad F
    Thromb Res; 2006; 117(6):705-11. PubMed ID: 15990159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and assessment of enzyme immunoassay for platelet-derived microparticles.
    Osumi K; Ozeki Y; Saito S; Nagamura Y; Ito H; Kimura Y; Ogura H; Nomura S
    Thromb Haemost; 2001 Feb; 85(2):326-30. PubMed ID: 11246556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new method for the detection of platelet derived microparticles by cytometric bead array and its evaluation].
    Li CB; Wang JZ; Wu X; Yuan JY; Wang R; Zhang AY; Zhao YJ; Qu CX; Wang XH
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1629-32. PubMed ID: 16185532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
    Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
    Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advancement of platelet activation measurement: focusing on platelet-derived microparticle measurement].
    Hayasaka K; Moriyama T; Chiba H; Matsuno K
    Rinsho Byori; 2006 Mar; 54(3):250-5. PubMed ID: 16637573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Method comparison of flow cytometric assay of platelet microparticles and changes of platelet microparticles during cancer chemotherapy.
    Kim HK; Song KS; Park YS; Kim CM; Lee KR
    Thromb Haemost; 2002 Mar; 87(3):547-8. PubMed ID: 11916095
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of platelet microparticles during cardiopulmonary bypass by means of captured ELISA for GPIIb/IIIa.
    Miyamoto S; Marcinkiewicz C; Edmunds LH; Niewiarowski S
    Thromb Haemost; 1998 Aug; 80(2):225-30. PubMed ID: 9716142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations.
    Kim HK; Song KS; Lee ES; Lee YJ; Park YS; Lee KR; Lee SN
    Blood Coagul Fibrinolysis; 2002 Jul; 13(5):393-7. PubMed ID: 12138366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived microparticles - an updated perspective.
    Siljander PR
    Thromb Res; 2011 Jan; 127 Suppl 2():S30-3. PubMed ID: 21193112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of immuno-magnetic beads for direct capture of nanosized microparticles from plasma.
    Yuana Y; Osanto S; Bertina RM
    Blood Coagul Fibrinolysis; 2012 Apr; 23(3):244-50. PubMed ID: 22343682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric detection and procoagulant activity of circulating canine platelet-derived microparticles.
    Helmond SE; Catalfamo JL; Brooks MB
    Am J Vet Res; 2013 Feb; 74(2):207-15. PubMed ID: 23363344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zeptomole detection sensitivity of prostate-specific antigen in a rapid microtitre plate assay using time-resolved fluorescence.
    Härmä H; Soukka T; Lönnberg S; Paukkunen J; Tarkkinen P; Lövgren T
    Luminescence; 2000; 15(6):351-5. PubMed ID: 11114110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of human tumour necrosis factor-alpha (TNF-alpha) by time-resolved immunofluorometric assay.
    Turpeinen U; Stenman UH
    Scand J Clin Lab Invest; 1994 Oct; 54(6):475-83. PubMed ID: 7809581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The procoagulant properties of hyaluronic acid-collagen (I)/chitosan complex film.
    Hu Y; Wu Y; Cai J; Ma S; Wang X
    J Biomater Sci Polym Ed; 2009; 20(7-8):1111-8. PubMed ID: 19454172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence for systemic platelet activation during or after orthotopic liver transplantation.
    Pereboom IT; Adelmeijer J; van Leeuwen Y; Hendriks HG; Porte RJ; Lisman T
    Liver Transpl; 2009 Aug; 15(8):956-62. PubMed ID: 19642138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of tissue factor and platelet-derived particles on leukocytes during cardiopulmonary bypass by flow cytometry and immunoelectron microscopy.
    Chung J; Suzuki H; Tabuchi N; Sato K; Shibamiya A; Koyama T
    Thromb Haemost; 2007 Aug; 98(2):368-74. PubMed ID: 17721619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ThromboFix platelet stabilizer: advances in clinical platelet analyses by flow cytometry?
    Schmidt V; Hilberg T
    Platelets; 2006 Jun; 17(4):266-73. PubMed ID: 16769604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
    Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
    Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of time-resolved immunofluorometric assays for CA 72-4 and application in sera of patients with gastric tumors.
    Sheng SL; Wang Q; Huang G
    Clin Chim Acta; 2007 May; 380(1-2):106-11. PubMed ID: 17321510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.